Statistics

Total Visits

Views
Bosutinib shows low cross intolerance, in chronic myeloid leukemia patients treated in fourth line. Results of the Spanish compassionate use program103

Select a period of time:

Number of views in the range

Views
Bosutinib shows low cross intolerance, in chronic myeloid leukemia patients treated in fourth line. Results of the Spanish compassionate use program26

Views

Views
September 20253
October 20252
November 20252
December 20251
January 202615
February 20261
March 20262
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States16
Argentina2
Australia1
Brazil1
China1
Germany1
Ecuador1
Ethiopia1
United Kingdom1
Paraguay1
 

Top cities views

Views
San Jose10
Addis Ababa1
Alcorta1
Bell Ville1
Cerro Grande do Sul1
Machala1
Nuremberg1
Salto del Guairá1